Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Systematic review of 24 observational studies (1,883 patients with SLE) with meta-analyses: anti-dsDNA, anti-RNP, anti-Sm, CCL21 and IP-10 showed associations with pulmonary disease or related outcomes; certainty of evidence was very low.
Meta-analysisn = 1,883
Langkilde et al. Circulating biomarkers and detection of pulmonary diseases in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studiesRCT of 225 patients having arterial surgery via a groin incision: intradermal sutures were not superior to metallic staples for 28-day surgical-site infection (7.1% vs 5.3%; RR 1.4, 95% CI 0.5-3.8, not significant).
RCTn = 225
González-Sagredo et al. Randomized clinical trial of intradermal suture and metallic stapling for incisional groin closure after vascular surgery (VASC-INF trial)ANSWER-HF RCT in 190 patients with Chagas cardiomyopathy and HFrEF: sacubitril-valsartan vs enalapril did not significantly improve LVEF at 6 months (+2.1% vs +1.2%; P=0.36). Secondary: NT-proBNP was lower and win ratio favoured sacubitril-valsartan (1.80).
RCTn = 190
Madrini et al. Sacubitril-Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: Primary Results of ANSWER-HF Randomized TrialSystematic review (22 RCTs, 27,082 participants; 7 non-randomised studies) with meta-analysis: education programmes for living kidney donor solicitation increased enquiries (RR 1.65), solicitation (RR 1.86) and transplants (RR 4.01) vs usual care; very low certainty.
Meta-analysisn = 29 studies
Cooper et al. Interventions to Improve Living Kidney Donor Solicitation: A Systematic Review and Meta-analysisMeta-analysis of 9 non-randomised studies in stage I ovarian clear cell carcinoma: adjuvant chemotherapy vs no intervention was associated with better disease-free survival (adjusted HR 0.47, 95% CI 0.29-0.74); overall survival HR 0.66 (95% CI 0.43-1.00).
Meta-analysisn = 9 studies
Inayama et al. Adjuvant Chemotherapy in Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-analysisUpdated SITC and INMC consensus guideline for pan-tumour scoring of pathologic response after neoadjuvant therapy: total submission of tumours ≤3 cm, quantification of residual viable tumour, necrosis and regression, and a standardised reporting template.
Guideline
Deutsch et al. Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: a joint SITC and INMC effortSecondary analysis of VITAL-AF (30,265 patients ≥65): 29% of 988 incident AF cases were stressor-associated. Oral anticoagulation within 90 days was lower than for primary AF (56% vs 75%); bleeding, stroke or death risk was high in both (HR 6.13, 3.91 vs no AF).
Secondary analysisn = 30,265
Haimovich et al. Incidence, Risk Factors, and Outcomes in Stressor-Associated Atrial Fibrillation: Insights From the VITAL-AF TrialPost hoc analysis of OCCUPI in 790 ACS patients with complex lesions: OCT-guided vs angiography-guided PCI had lower 1-year MACE (4.9% vs 9.5%; HR 0.50, 95% CI 0.29-0.87). No significant interaction with presentation (p=0.273).
Secondary analysisn = 790
Lee et al. Optical coherence tomography-guided percutaneous coronary intervention in acute coronary syndrome patients with complex lesions: a subgroup analysis of the randomised OCCUPI TrialPrespecified secondary analysis of CONFIDENCE in type 2 diabetes with CKD and albuminuria: hyperkalaemia occurred in 15.1% with empagliflozin plus finerenone, 18.8% with finerenone and 9.7% with empagliflozin; the combination did not significantly reduce risk vs finerenone.
Secondary analysisn = 779
Agarwal et al. Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized TrialSecondary pooled analysis of BASIL-3 (481 patients with chronic limb-threatening ischaemia): drug-coated balloons or drug-eluting stents vs plain balloon angioplasty showed similar overall survival at median 5.6 years (adjusted HR 0.83, 95% CI 0.64-1.07).
Secondary analysisn = 481
Popplewell et al. Long-term mortality rate and clinical outcomes associated with femoro-popliteal drug-coated balloon angioplasty and drug-eluting stents in chronic limb-threatening ischaemia: an analysis of the BASIL-3 RCT